Atlas Trials

Vaxcyte, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vaxcyte, Inc.

RecordFirmDate
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults (NCT07616934)Vaxcyte, Inc.2026-06-01
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination (NCT07425392)Vaxcyte, Inc.2026-02-09
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age (NCT07365826)Vaxcyte, Inc.2026-01-12
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49 (NCT07284654)Vaxcyte, Inc.2025-12-01
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants (NCT06720038)Vaxcyte, Inc.2024-11-25
Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults (NCT06151288)Vaxcyte, Inc.2023-11-08
Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants (NCT05844423)Vaxcyte, Inc.2023-03-29
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults (NCT05297578)Vaxcyte, Inc.2022-06-15
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults (NCT05266456)Vaxcyte, Inc.2022-02-22

Track Vaxcyte, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.